Filter Results:
(64)
Show Results For
- All HBS Web
(64)
- News (30)
- Research (19)
- Multimedia (1)
- Faculty Publications (8)
Show Results For
- All HBS Web
(64)
- News (30)
- Research (19)
- Multimedia (1)
- Faculty Publications (8)
- Web
Named Fellowship Funds - Alumni
(MBA 1977/JD 1978). Shortly after her birth on March 31, 1992, Clare was diagnosed with biliary atresia, a rare pediatric liver disease, and after two liver transplants, she died at 16 months. Clare's parents wished to make a meaningful... View Details
- 14 Jul 2023
- Blog Post
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows
synthetic biology and data science company that’s digitizing taste and smell. Morgan previously ran business development and fundraising at Trellis Bioscience, a clinical-stage Series C startup developing rare native human antibodies... View Details
- Web
2023 Reunion Presentations - Alumni
board of directors, and what that board could/should have done differently to protect longstanding ESG values at the company. Participants left the session with a better understanding of the corporate law and business issues raised in complex corporate deals. Slides... View Details
- 01 Dec 2023
- News
Wide Horizon
startup that was developing a treatment for some rare condition, with the directive to “get smart” on it before a Friday meeting. He knew how and where to look for answers. As he started to read more of the research, he did indeed find... View Details
Keywords: Dan Morrell; Photos by Sarah Wilson
- Web
Publications - Institute For Strategy And Competitiveness
Mayumi Kharabi, and Robert S. Kaplan In this study the authors sought to apply a value (outcomes and cost) analysis to extracorporeal life support (ECLS), a relatively rare but very expensive ICU therapy with highly variable outcomes.... View Details
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
Nora Rabah (MS/MBA 2022), who emigrated to the United States as a child, remembers the hardship of growing up without health care and wants to make drugs for children with rare diseases more accessible and... View Details
- Web
Doubling Down on Women’s Health Innovation and Leveraging the Private Sector in a Post-Roe v. Wade Era - Blog: Health Supplement
rely on their grandmother’s hormonal products. You Might Want to Read 24 May 2023 Student Spotlight: 2023 HCC Co-Presidents Reflect on Their Time at HBS and the Current Health Care Systems Morgan Moncada & Hannah Truong 28 Feb 2023 Rare... View Details
- 31 Jan 2014
- News
Body, Heal Thyself
messenger RNA (mRNA) Therapeutics. The data that Bancel saw that evening were shocking. The numbers suggested Moderna had found an entirely new way to treat diseases—one that promised to change the medical world, resulting in cures for View Details
- Profile
Emily Schlichting
At age 19, in the spring of 2009, Emily Schlichting was diagnosed with Behcet's, a rare autoimmune disease that introduced her "to the realities of U.S. health care firsthand." Although the View Details
- 01 Jun 2023
- News
From Big Pharma to Startup
Hunter Goble (MBA 2022) did not enroll in Harvard Business School with dreams of becoming an entrepreneur. After earning his MBA, Goble intended to return to Eli Lilly to continue to work building brands and launching products. He envisioned himself leading a big,... View Details
Keywords: April White
- 22 Aug 2022
- Research & Ideas
Can Amazon Remake Health Care?
we desperately need more meaningful innovation for a whole host of diseases—diabetes, cardiovascular disease, Parkinson’s, Alzheimer’s, and ALS. We want cures, not chronic disease management. How does Amazon’s foray into health care help... View Details
- 30 Jul 2007
- Research & Ideas
Repugnant Markets and How They Get That Way
was get some of the gains from exchange without exciting the repugnance that forbids markets. One could imagine that a law about kidney sales might come about if the courts decided that it was unreasonable for someone who was dying of kidney View Details
Keywords: by Martha Lagace
- 15 Dec 2003
- Research & Ideas
The New Global Business Manager
Massachusetts. Their Cerezyme plant runs twenty-four hours a day, 365 days a year, and produces six kilos of product in all that time. You could fit it in a little six-pack bag. But it is sufficient to treat the 6,000 people around the world—and that's all there... View Details
Keywords: by Cynthia Churchwell
- 17 Dec 2007
- Research & Ideas
The Rise of Medical Tourism
What used to be rare is now commonplace: traveling abroad to receive medical treatment, and to a developing country at that. So-called medical tourism is on the rise for everything from cardiac care to plastic surgery to hip and knee... View Details
- 25 Aug 2022
- News
Up on the Corner
these redlined areas form the shape of a so-called Black butterfly, and they suffer the highest rates of poverty, crime, and chronic disease in the city. Studies show that investment is far lower in predominantly Black neighborhoods than... View Details
- 25 Apr 2014
- News
A revolution in healing
formerly was CEO of bioMérieux. He joined the company in 2011 after seeing impressive data indicating Moderna had found an entirely new way to treat rare diseases and cancer—using technology that was... View Details
- 23 Jan 2019
- News
The Promise of Personalized Medicine
muscle weakness and loss. MORE Watch a video about Horgan’s experience as a Blavatnik Fellow Read more about Cure Rare Disease MORE Watch a video about Horgan’s experience as a Blavatnik Fellow Read more... View Details
- 06 Dec 2021
- News
Vision: Sound Science
doctorate in biomedical engineering and readily admits he still identifies as a scientist, is equally excited about the big-picture impact of receiving orphan drug and rare pediatric disease designations.... View Details
Keywords: Deb Blagg
- Web
THE VALUE OF THE PHYSICIAN SHADOW PROGRAM: Witnessing The Front Lines of Care Delivery - Blog: Health Supplement
Might Want to Read 24 May 2023 Student Spotlight: 2023 HCC Co-Presidents Reflect on Their Time at HBS and the Current Health Care Systems Morgan Moncada & Hannah Truong 28 Feb 2023 Rare Disease Day – Small... View Details
- 01 Sep 2003
- News
Richard Edelman
well. Appointed the firm’s CEO in 1997, he believes that there is usually an intersection of corporate and public interest. “Change is rarely revolutionary,” he says cheerfully. “You do better by being inside the tent.” Since earning his... View Details